Ulrik Svane Sørensen
Oprichter bij Acesion Pharma ApS
Actieve functies van Ulrik Svane Sørensen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Acesion Pharma ApS
 Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Oprichter | 01-01-2011 | - |
| Operationeel Directeur | 01-01-2016 | - | |
| Algemeen Directeur | 01-01-2011 | 01-01-2016 |
Loopbaan van Ulrik Svane Sørensen
Opleiding van Ulrik Svane Sørensen
| Copenhagen Business School | Doctorate Degree |
Statistieken
Internationaal
| Denemarken | 3 |
Operationeel
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
| Founder | 1 |
Sectoraal
| Health Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Acesion Pharma ApS
Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Health Technology |
